[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grail Inc (GRAL)

Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,957,410
  • Shares Outstanding, K 42,917
  • Annual Sales, $ 147,170 K
  • Annual Income, $ -408,350 K
  • EBIT $ -516 M
  • EBITDA $ -353 M
  • 60-Month Beta 3.22
  • Price/Sales 21.18
  • Price/Cash Flow N/A
  • Price/Book 1.24

Options Overview Details

View History
  • Implied Volatility 88.86% (+5.46%)
  • Historical Volatility 57.80%
  • IV Percentile 46%
  • IV Rank 45.86%
  • IV High 114.54% on 10/30/25
  • IV Low 67.09% on 09/04/25
  • Expected Move (DTE 31) 11.65 (16.90%)
  • Put/Call Vol Ratio 0.29
  • Today's Volume 526
  • Volume Avg (30-Day) 583
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 16,929
  • Open Int (30-Day) 22,195
  • Expected Range 57.27 to 80.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-2.91
  • Number of Estimates 2
  • High Estimate $-2.84
  • Low Estimate $-2.98
  • Prior Year $-3.18
  • Growth Rate Est. (year over year) +8.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.00 +14.85%
on 06/23/26
76.07 -9.41%
on 07/10/26
+5.17 (+8.11%)
since 06/18/26
3-Month
49.15 +40.20%
on 04/29/26
79.50 -13.32%
on 05/28/26
+17.71 (+34.59%)
since 04/20/26
52-Week
29.95 +130.08%
on 08/20/25
118.84 -42.01%
on 01/22/26
+33.72 (+95.82%)
since 07/18/25

Most Recent Stories

More News
Lawsuit Notice: $GRAL Legal News: GRAIL, Inc. Trial Results and 50% Stock Drop Trigger Securities Fraud Class Action

A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL's NHS-Galleri cancer...

GRAL : 68.91 (-5.11%)
GRAIL, Inc. Deadline: GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit

NEW YORK , July 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminders purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19,...

GRAL : 68.91 (-5.11%)
GRAL DEADLINE: SueWallSt Reminds Grail, Inc. Investors of Upcoming Securities Class Action Deadline

Time-Sensitive: Allegations Focus on Defendants' Refusal to Share Detailed NHS-Galleri Data, Potentially Concealing Adverse Trendlines From Investors

GRAL : 68.91 (-5.11%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines - GRAL

NEW YORK , July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. ("Grail" or the "Company") (NASDAQ: GRAL).  Such investors are advised...

GRAL : 68.91 (-5.11%)
Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans

MENLO PARK, Calif. , July 16, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a collaboration with...

GRAL : 68.91 (-5.11%)
INVESTOR NOTICE: GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman

SAN FRANCISCO , July 16, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman is investigating claims in a pending class action alleging violations of U.S. securities laws by GRAIL,...

GRAL : 68.91 (-5.11%)
GRAL Fraud Notice: GRAIL, Inc. Investors are Reminded to Contact BFA Law about the Filed Securities Fraud Class Action Lawsuit to Recover Investment Losses

A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL’s NHS-Galleri cancer trial,...

GRAL : 68.91 (-5.11%)
GRAL Shareholder Alert: Grail, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Alert: Claims Focus on Alleged Misrepresentations About Whether the NHS-Galleri Trial's Three-Year Design Could Deliver Its Primary Endpoint of Reduced Late-Stage Cancers

GRAL : 68.91 (-5.11%)
INVESTOR NOTICE: GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman

SAN FRANCISCO , July 14, 2026 /PRNewswire/ -- On February 20, 2026, GRAIL, Inc. ( NASDAQ: GRAL ) shed over $2.2 billion of market capitalization after surprising investors with its NHS-Galleri...

GRAL : 68.91 (-5.11%)
Grail, Inc. (GRAL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , July 14, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP  announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

GRAL : 68.91 (-5.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 75.37
2nd Resistance Point 73.97
1st Resistance Point 71.44
Last Price 68.91
1st Support Level 67.51
2nd Support Level 66.11
3rd Support Level 63.58

See More

52-Week High 118.84
Fibonacci 61.8% 84.88
Fibonacci 50% 74.39
Last Price 68.91
Fibonacci 38.2% 63.91
52-Week Low 29.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.